Chongqing Hilan Pharmaceutical Co., Ltd.

The main purpose of the study is to observe the pharmacokinetic characteristics of the test preparation crisaborole ointment [Specification: 2% (30 g: 0.6 g), produced by Chongqing Xi'an Pharmaceutical Co., Ltd.] and the reference preparation crisaborole ointment [trade name: Staquis®, specification: 2%, licensed by Anacor Pharmaceuticals, Inc., produced by Pharmacia and Upjohn Company LLC] in Chinese healthy subjects after single topical application under fasting conditions, estimate the pharmacokinetic parameters of the two preparations, and evaluate the bioequivalence between the two preparations. Secondary purpose of the study: to observe the safety of the test preparation and reference preparation of crisaborole ointment in healthy subjects.

Evaluation of the effectiveness and safety of Shugan Shunqi Pills in treating functional dyspepsia

To evaluate the efficacy and safety of Jinchan Zhiyang Capsule in subacute eczema (endogenous damp-heat syndrome) and provide a basis for its new indication of subacute eczema.